Management of Headache Related to COVID-19-Reference-Cited by-同舟云学术

Management of Headache Related to COVID-19

Published:2023 Issue: Volume: Page:153-164
ISSN:2197-652X
Container-title:Headache Disorders in Pandemic Conditions
language:
Short-container-title:

Author:

Garcia-Azorin David^ORCID,Díaz de Terán Javier^ORCID,González-Quintanilla Vicente^ORCID,Gago-Veiga Ana Beatriz^ORCID,González-Martínez Alicia^ORCID,Echavarría-Íñiguez Ana^ORCID,Guerrero Peral Ángel Luis^ORCID

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-26309-5_14

Reference40 articles.

1. García-Azorín D, Sierra Á, Trigo J, Alberdi A, Blanco M, Calcerrada I, Cornejo A, Cubero M, Gil A, García-Iglesias C, Lozano AG, Martínez Badillo C, Montilla C, Mora M, Núñez G, Paniagua M, Pérez C, Rojas M, Ruiz M, Sierra L, Hurtado ML, Guerrero Peral ÁL. Frequency and phenotype of headache in covid-19: a study of 2194 patients. Sci Rep. 2021;11(1):14674. https://doi.org/10.1038/s41598-021-94220-6.

2. Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, Mencia ÁS, Segura T, Gonzalez-García N, Díaz-de-Terán J, Gallardo VJ, Gago-Veiga AB, Ballvé A, Trigo López J, Sastre-Real M, Llauradó A, Cornejo A, de Lorenzo Í, Guerrero-Peral Á, Pozo-Rosich P. Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia. 2022;42(8):804–9. https://doi.org/10.1177/03331024211068074.

3. Arca KN, Smith JH, Chiang CC, Starling AJ, Robertson CE, Halker Singh RB, Schwedt TJ, Kissoon NR, Garza I, Rozen TD, Boes CJ, Whealy MA, VanderPluym JH. COVID-19 and headache medicine: a narrative review of non-steroidal anti-inflammatory drug (NSAID) and corticosteroid use. Headache. 2020;60(8):1558–68. https://doi.org/10.1111/head.13903.

4. Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and COVID-19: a systematic review and meta-analysis. Drug Saf. 2021;44(9):929–38. https://doi.org/10.1007/s40264-021-01089-5.

5. Graham GG, Scott KF, Day RO. Tolerability of paracetamol. Drug Saf. 2005;28(3):227–40. https://doi.org/10.2165/00002018-200528030-00004.